Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Takahito Fukusumi
Affiliation
Osaka University Graduate School of Medicine
ORCID
Career Start Year
2012
Papers
51
H Index
18
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36787504
Clearance Profile of Circulating Tumor Human Papillomavirus DNA During Radiotherapy Predicts Clinical Outcomes in Human Papillomavirus-Related Oropharyngeal Cancer.
JCO Precis Oncol
2023
38022262
Microscopic Residual Disease After Nasal Squamous Cell Carcinoma Not Visualized on FDG PET-CT: A Case Report.
Cureus
2023
38059478
Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
Acta Otolaryngol
2023
37272954
Activated fibroblasts in muscle sarcoidosis revealed by [<sup>18</sup>F]FAPI-74 PET.
Eur J Nucl Med Mol Imaging
2023
34486724
Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Int J Cancer
2022
32895945
Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck.
Int J Cancer
2021
33491747
Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma.
Int J Oncol
2021
33813412
Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer.
Anticancer Res
2021
34366245
Corrigendum to "Prevalence of human papillomavirus in oral gargles and tonsillar washings" [Oral Oncol. 105 (2020) 104669].
Oral Oncol
2021
33373656
Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.
Int J Radiat Oncol Biol Phys
2021
33368784
Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.
Head Neck
2021
32259682
Prevalence of human papillomavirus in oral gargles and tonsillar washings.
Oral Oncol
2020
31721164
A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Cancer
2020
31850594
Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.
Head Neck
2020
32848210
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.
Oncogene
2020
30933315
Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Cancer
2019
31444114
Successful control of T4 and N3 human papillomavirus-related oropharyngeal squamous cell carcinoma after de-intensified chemoradiotherapy: Report of two cases.
Oral Oncol
2019
31097695
Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.
Nat Commun
2019
31142745
Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.
Nat Commun
2019
31109690
Metabolic tumor volume of metastatic lymph nodes and survival after total laryngectomy in laryngeal and hypopharyngeal cancer.
Oral Oncol
2019
29146722
The <i>NOTCH4</i>-<i>HEY1</i> Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
2018
29945995
Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
Clin Cancer Res
2018
30070359
Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Int J Cancer
2018
29489439
The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.
J Dent Res
2018
28084858
Age-adjusted Charlson comorbidity index as a prognostic factor of hypopharyngeal cancer treated with chemoradiation therapy.
Acta Otolaryngol
2017
27166395
Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity.
Clin Cancer Res
2016
27732629
Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.
PLoS One
2016
24890618
Prognostic significance of body mass index before treatment for head and neck cancer.
Head Neck
2015
26330103
Cancer stem cells: The potential of carbon ion beam radiation and new radiosensitizers (Review).
Oncol Rep
2015
26115903
Factors predicting severe infections during chemotherapy in head and neck cancer patients.
Acta Otolaryngol
2015
26137071
Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26.
Oncol Lett
2015
25622661
Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.
Acta Otolaryngol
2015
25586680
Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG-inactivating β-oxygenation pathway in colorectal cancer.
Int J Oncol
2015
24378718
Novel drug discovery system for cancer stem cells in human squamous cell carcinoma of the esophagus.
Oncol Rep
2014
25269626
Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity.
Int J Oncol
2014
25269542
Visualization and characterization of cancer stem-like cells in cervical cancer.
Int J Oncol
2014
25131392
Factors associated with malnutrition in patients with head and neck cancer.
Acta Otolaryngol
2014
24874475
CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma.
Br J Cancer
2014
24317739
Cells of origin of squamous epithelium, dysplasia and cancer in the head and neck region after bone marrow transplantation.
Int J Oncol
2014
23354547
Depletion of JARID1B induces cellular senescence in human colorectal cancer.
Int J Oncol
2013
24649241
Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.
Mol Clin Oncol
2013
24649116
Eradication of therapy-resistant cancer cells in gastrointestinal organs.
Mol Clin Oncol
2013
23848007
[Cancer stem cells depend on their own niche].
Gan To Kagaku Ryoho
2013
23452121
Adipose-derived mesenchymal stem cells and regenerative medicine.
Dev Growth Differ
2013
23440340
Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Int J Oncol
2013
22151786
Reprogramming of gastrointestinal cancer cells.
Cancer Sci
2012
22293932
Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
Int J Oncol
2012
22446887
Dicer 1, ribonuclease type III modulates a reprogramming effect in colorectal cancer cells.
Int J Mol Med
2012
22735680
Transcriptomic study of dormant gastrointestinal cancer stem cells.
Int J Oncol
2012
23060915
microRNA-based cancer cell reprogramming technology.
Exp Ther Med
2012
1 - 50 of 51
Column Actions
Search
Recommended Authors
Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year
2016
Number of shared co-authors
0
Hua Li
University of California san francisco
Career Start Year
2013
Number of shared co-authors
1
Stefan Hartmann
University Hospital Wurzburg
Career Start Year
2013
Number of shared co-authors
0
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2010
Number of shared co-authors
0
Farhoud Faraji
University of California San Diego Health
Career Start Year
2008
Number of shared co-authors
12
Pinaki Bose
Cumming School of Medicine, University of Calgary
Career Start Year
2008
Number of shared co-authors
0
Julie E Bauman
George Washington University
Career Start Year
2007
Number of shared co-authors
6
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year
2006
Number of shared co-authors
0
Stephen B Keysar
University of Colorado Denver
Career Start Year
2006
Number of shared co-authors
1
Sophia Bornstein
Cornell University
Career Start Year
2005
Number of shared co-authors
0
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year
2004
Number of shared co-authors
1
Sabrina Daniela da Silva
Jewish General Hospital
Career Start Year
2004
Number of shared co-authors
0
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year
2002
Number of shared co-authors
0
Ezra E W Cohen
university of california san diego Health System
Career Start Year
2001
Number of shared co-authors
13
Anthony C Nichols
University of Western Ontario
Career Start Year
2001
Number of shared co-authors
0
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year
2000
Number of shared co-authors
0
Sana D Karam
University of Colorado School of Medicine
Career Start Year
2000
Number of shared co-authors
1
Hyunseok Kang
Johns Hopkins University
Career Start Year
2000
Number of shared co-authors
7
Rifat Hasina
University of Chicago Medicine
Career Start Year
1999
Number of shared co-authors
0
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year
1999
Number of shared co-authors
5
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
3
Mitchell J Frederick
Baylor College of Medicine
Career Start Year
1995
Number of shared co-authors
8
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Career Start Year
1991
Number of shared co-authors
3
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year
1988
Number of shared co-authors
1
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
1
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
13
Jennifer R Grandis
University of California san francisco
Career Start Year
1988
Number of shared co-authors
11
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year
1987
Number of shared co-authors
2
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year
1986
Number of shared co-authors
1
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Career Start Year
1986
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Joseph A Califano
University of California
Co-authored papers
11
Shuling Ren
Beijing Friendship Hospital, Capital Medical University
Co-authored papers
10
Mizuo Ando
University of Tokyo
Co-authored papers
10
Akihiro Sakai
Tokai University
Co-authored papers
10
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers
9
Chao Liu
Xiangya Hospital, Central South University
Co-authored papers
9
Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Co-authored papers
6
Sayed Sadat
Moores Cancer Center, University of California San Diego
Co-authored papers
6
Yuki Saito
Niigata Prefectural Tokamachi Hospital.
Co-authored papers
6
Guorong Xu
Chinese University of Hong Kong
Co-authored papers
6
Sunny Haft
Moores Cancer Center, University of California
Co-authored papers
6
Alexander V Favorov
Johns Hopkins School of Medicine
Co-authored papers
5
John Pang
University of Washington
Co-authored papers
4
Elana J Fertig
Johns Hopkins University School of Medicine
Co-authored papers
4
Zubair Khan
University of Texas at Houston Health Science Center
Co-authored papers
4
Daria A Gaykalova
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers
4
Pablo Tamayo
University of California San Diego
Co-authored papers
3
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers
3
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers
2
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Co-authored papers
2
Patrick K Ha
University of California San Francisco
Co-authored papers
2
Minya Pu
University of California
Co-authored papers
2
Tatsuya Yamasoba
The University of Tokyo
Co-authored papers
2
Karen Messer
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers
2
Kate Medetgul-Ernar
University of California San Diego Health Moores Cancer Center.
Co-authored papers
2
Nam Q Bui
University of California San Diego
Co-authored papers
1
Michael M Allevato
University of Michigan Medical School.
Co-authored papers
1
Nam Q Bui
University of California San Diego
Co-authored papers
1
Jessica Santos
Moores Cancer Center, University of California San Diego
Co-authored papers
1
Alfredo A Molinolo
University of California
Co-authored papers
1
1 - 30